Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
China NT Pharma Group Co., Ltd. ( (HK:1011) ) has shared an update.
China NT Pharma Group Co., Ltd. has announced a potential acquisition and disposal involving its associate, Beijing Kangchen Biotechnology Company Limited. The proposed plan involves splitting the assets of the associate to protect shareholder interests, with the intention of dissolving the associate relationship and allowing independent operations. This move could impact the company’s operations by potentially expanding its asset base and altering its industry positioning, depending on the outcome of negotiations with Konruns Pharmaceutical.
More about China NT Pharma Group Co., Ltd.
China NT Pharma Group Co., Ltd. operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company is involved in the production of various medical treatments and has a market focus on both domestic and international pharmaceutical sectors.
Average Trading Volume: 1,322,741
Technical Sentiment Signal: Hold
Current Market Cap: HK$229.2M
For detailed information about 1011 stock, go to TipRanks’ Stock Analysis page.